- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT04257409
Musculoskeletal Changes After Physiotherapeutic Intervention in Podiatric Subjects (BIONEDIAN)
Musculoskeletal Changes Induced by Physiotherapeutic Intervention, and Their Impact on the Induction of Diabetic Foot Syndrome and Psychosocial Status in Type 2 Diabetes Mellitus
The recurrence of diabetic foot ulcers (DFU) is a key problem in podiatric care. It is very often given by biomechanical abnormalities frequently present in those patients. The aim of our randomized controlled study is to find possible changes as of plantar pressures as of biomechanics of the ankle and small joints in patients with type 2 diabetes mellitus with different degrees of neuropathy. During this project, investigators will examine the possible impact of 12-week lasting intervention program on the distribution of plantar pressures, joint mobility and muscle strength of lower limbs. The incidence of ulcerations / reulcerations and changes of psychosocial characteristics will be evaluated during the study period.
Approximately 60 patients with Type 2 diabetes mellitus will be included into the study. These patients will be randomized into 3 study groups - patients with type 2 DM with mild form of peripheral sensory neuropathy (20 subjects), patient with severe peripheral neuropathy (20 subjects) and those with diabetic foot syndrome, without active lesion (20 subjects). All patients will undergo 12 week lasting active intervention program consisting of recommendations by a physiotherapist focusing on the improvement of physical fitness, muscle strength and foot joint improvement. Control group will be consisted of 20 patients with healed diabetic foot.
The outcomes of this project will try to objectively verify in the randomized controlled trial the impact of exercise on lower limb biomechanics, mobility, self-sufficiency, quality of life in patients with type 2 diabetes mellitus at risk or already developed diabetic foot syndrome.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Antecipado)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Prague, Tcheca, 14200
- Recrutamento
- Institute for Clinical and Experimental Medicine
-
Contato:
- Eliška Vrátná, Mgr.
- Número de telefone: +420774549214
- E-mail: vratnae@gmail.com
-
Contato:
- Vladimíra Fejfarová, MD, PhD
- Número de telefone: +420603877381
- E-mail: vlfe@medicon.cz
-
Subinvestigador:
- Jitka Hazdrová, MD
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Type 2 diabetes mellitus
- sensoric neuropathy (mild - based on VPV 15-30 V or EMG results, severe - based on VPT above 50 V or EMG results)
- diabetic foot with healed diabetic foot ulcers, inactive Charcot foot
Exclusion Criteria:
- impossibility to exercise
- amaurosis
- non-compliance
- critical limb ischemia
- active ulcer, surgical wound
- active Charcot foot
- active carcinoma
- recent stroke (last 8 weeks)
- recent myocardial infarction (last 8 weeks)
- recent PTA, PCI, bypass (last 8 weeks)
- myopathy
- rheumatoid arthritis
- cox-, gonartrosis of 3rd -4th grade.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
---|---|
Experimental: DF patient active
Patients with Type 2 diabetes mellitus and diabetic foot, whose have healed diabetic foot ulcers
|
12 week lasting exercise intervention
|
Comparador Ativo: DF patient control
Patients with Type 2 diabetes mellitus and diabetic foot, whose have healed diabetic foot ulcers
|
12 week lasting exercise intervention
|
Experimental: Diabetic patient with mild neuropathy
Patients with Type 2 diabetes mellitus with mild form of peripheral sensory neuropathy
|
12 week lasting exercise intervention
|
Experimental: Diabetic patient with severe neuropathy
Patients with Type 2 diabetes mellitus with severe form of peripheral sensory neuropathy
|
12 week lasting exercise intervention
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Biomechanics- plantar pressures
Prazo: changes after 12 weeks, 24 weeks
|
plantar pressures will be evaluated by pedobarograph (in Newtons)
|
changes after 12 weeks, 24 weeks
|
Biomechanics- biomechanics of the ankle
Prazo: changes after 12 weeks, 24 weeks
|
biomechanics of the ankle will be assessed by goniometry in angles
|
changes after 12 weeks, 24 weeks
|
Biomechanics- changes of foot joint angles
Prazo: changes after 12 weeks, 24 weeks
|
changes of foot joint agles will be evaluated by measurement of X-Rays bones angles - calcaneal pitch, talar-1st metatarsal angle and lateral Talocalcaneal angle
|
changes after 12 weeks, 24 weeks
|
Fitness - physical activity
Prazo: changes after 12 weeks, 24 weeks
|
The amount of physical activity will be assessed by IPAQ questioners
|
changes after 12 weeks, 24 weeks
|
Fitness - muscle strength
Prazo: changes after 12 weeks, 24 weeks
|
Muscle strength will be measured by dynamometry in Newtons
|
changes after 12 weeks, 24 weeks
|
Fitness - senior fitness
Prazo: changes after 12 weeks, 24 weeks
|
fitness will be assessed by seniorfittest containing 2 minutes step test (steps/2 min) and test of sitting (sits/30 seconds)
|
changes after 12 weeks, 24 weeks
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
ulceration/reulceration
Prazo: changes after 12 weeks, 24 weeks
|
detection of the incidence of ulceration/reulceration
|
changes after 12 weeks, 24 weeks
|
Psychosocial changes - quality of life
Prazo: changes after 12 weeks, 24 weeks
|
Quality of life will be evaluated by WHO-QoL Bref test (4 domains - high values mean bettr findings
|
changes after 12 weeks, 24 weeks
|
Psychosocial changes - depression
Prazo: changes after 12 weeks, 24 weeks
|
Depression status will be asessed by Geriatric Depression Scale (GDS) scale - minimum 0, maximum 30 points (higher then 9 points- mild form of depression, higher then 20 - severe depression
|
changes after 12 weeks, 24 weeks
|
Psychosocial changes - stress readaptation
Prazo: changes after 12 weeks, 24 weeks
|
Adaptation to stress will be detected by Stress Readaption Scale (0-400 points) - points higher then 150 - higher risk of worse stress readaptation and therefore higher risk of somatisation
|
changes after 12 weeks, 24 weeks
|
Metabolism - glucose control
Prazo: changes after 12 weeks, 24 weeks
|
Investigators will be loked for metabolic changes in diabetes control (HbA1c in mmol/mol, glycemia in mmol/l)
|
changes after 12 weeks, 24 weeks
|
Metabolism - lipid profile
Prazo: changes after 12 weeks, 24 weeks
|
The authors will control lipid profiles (Total-, HDL-, LDL-cholesterol in umol/l)
|
changes after 12 weeks, 24 weeks
|
Metabolism - myokines
Prazo: changes after 12 weeks, 24 weeks
|
Patients will be checked for changes in selected cytokines nad myokines (IL-4,6,7,8,15 in pg/ml, myostatin in pg/ml, irisin in ng/ml, FGF-21 in pg/ml)
|
changes after 12 weeks, 24 weeks
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Antecipado)
Conclusão do estudo (Antecipado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 546417
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .